Improved Technique for Establishing Short Term Human Brain Tumor Cultures Maxine A. Farr-JonesIan F. ParneyKenneth C. Petruk OriginalPaper Pages: 1 - 10
Sequential Imaging and Volumetric Analysis of an Intracerebral C6 Glioma by Means of a Clinical MRI System Frank A. RailaAlfred P. BowlesAllen Terrell OriginalPaper Pages: 11 - 17
Expression of PECAM-1/CD31 Isoforms in Human Brain Gliomas Frédérique ArocaWanda RenaudDominique Figarella-Branger OriginalPaper Pages: 19 - 25
Suppression of TGF-β1 in Human Gliomas by Retroviral Gene Transfection Enhances Susceptibility to LAK Cells Ryuya YamanakaRyuichi TanakaHirofumi Naganuma OriginalPaper Pages: 27 - 34
Presurgical Serum Albumin Levels Predict Survival Time from Glioblastoma Multiforme Judith A. SchwartzbaumPriya LalJames L. Fisher OriginalPaper Pages: 35 - 41
Topotecan for the Treatment of Recurrent or Progressive Central Nervous System Tumors – A Pediatric Oncology Group Phase II Study Richard P. KadotaClinton F. StewartRichard L. Heideman OriginalPaper Pages: 43 - 47
Blood Flow and Metabolism of Oligodendrogliomas: A Positron Emission Tomography Study with Kinetic Analysis of 18F-fluorodeoxyglucose Katsuyoshi MineuraHitoshi ShioyaKazuo Uemura OriginalPaper Pages: 49 - 57
Intracranial Involvement by Metastatic Advanced Gastric Carcinoma Manho Kim OriginalPaper Pages: 59 - 62
Simultaneous Presentation of Atypical Teratoid/Rhabdoid Tumor in Siblings F. ProustA. LaquerriereP. Fréger OriginalPaper Pages: 63 - 70
Salvage Chemotherapy with Taxol for Recurrent Anaplastic Astrocytomas Marc C. ChamberlainPatty Kormanik OriginalPaper Pages: 71 - 78
Gossypol Treatment of Recurrent Adult Malignant Gliomas Peter BushunowMarcus M. ReidenbergThomas Coyle OriginalPaper Pages: 79 - 86
Use of Different Outcome Measures in Randomised Studies of Malignant Glioma can Significantly Alter the Interpretation of Time to Progression: Reanalysis of the MRC BR2 Study Jeremy ChatawaySally StenningRobert Grant OriginalPaper Pages: 87 - 92
